Wilson Sonsini Goodrich & Rosati advised Microchip on the transaction, and Simpson Thacher & Bartlett represented the underwriters. Microchip Technology Incorporated (Microchip) priced an offering of...
Microchip Technology’s $2 Billion Investment Grade Notes Offering
Lumos Pharma’s Tender Offer and Merger with Double Point Ventures
Wilson Sonsini Goodrich & Rosati and Cooley advised Lumos Pharma on the transaction, while Foley & Lardner advised Double Point Ventures. Lumos Pharma (NASDAQ:LUMO), a clinical...
Takeda’s $75 Million Investment in Ascentage Pharma
Wilson Sonsini Goodrich & Rosati acted as the U.S. and Hong Kong counsel to Ascentage Pharma in the transaction. Ascentage Pharma Group International (Ascentage Pharma) (6855.HK)...
Microchip Technology’s $1 Billion Senior Notes Offering
Wilson Sonsini Goodrich & Rosati represented Microchip Technology Incorporated in the offering, and Simpson Thacher & Bartlett represented the underwriters. Microchip Technology Incorporated (Microchip) (Nasdaq: MCHP) priced...